Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Celldex Therapeutics Inc (CLDX)  
$33.01 0.25 (0.76%) as of 4:30 Wed 6/5


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 62,894,000
Market Cap: 2.08(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $22.61 - $51.88
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Diagnostic Substances

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies. Co.'s clinical development programs include: CDX-0159, which is a human monoclonal antibody that specifically binds the receptor tyrosine kinase KIT; CDX-1140, which is a human monoclonal antibody targeted to CD40, a key activator of immune response, which is being studied in a Phase1 study; and CDX-527, which is a bispecific antibody that uses Co.'s proprietary anti-PD-L1 and CD27 human antibodies to couple CD27 co-stimulation with blockade of the PD-L1/PD-1 pathway, for which Co. has initiated a Phase 1 study in advanced solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 246,388 246,388 246,388 470,243
Total Sell Value $8,325,092 $8,325,092 $8,325,092 $16,684,033
Total People Sold 6 6 6 9
Total Sell Transactions 7 7 7 15
End Date 2024-03-09 2023-12-07 2023-06-08 2022-06-08

   
Records found: 254
  Page 2 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Marucci Anthony S PRESIDENT & CEO   •       •      –    2022-08-15 4 OE $2.78 $614,243 D/D 120,000 147,692     -
   Wright Richard M. SR. VP & CCO   •       –      –    2022-08-15 4 S $37.71 $578,048 D/D (15,328) 208 -16%     
   Wright Richard M. SR. VP & CCO   •       –      –    2022-08-15 4 OE $10.38 $159,105 D/D 15,328 15,536     -
   Martin Samuel Bates SVP AND CFO   •       –      –    2022-08-12 4 S $34.62 $639,629 D/D (17,547) 24,378 -18%     
   Martin Samuel Bates SVP AND CFO   •       –      –    2022-08-12 4 OE $2.78 $72,953 D/D 17,547 41,925     -
   Martin Samuel Bates SVP AND CFO   •       –      –    2022-08-11 4 S $37.04 $90,856 D/D (2,453) 24,378 -31%     
   Martin Samuel Bates SVP AND CFO   •       –      –    2022-08-11 4 OE $9.02 $22,117 D/D 2,453 26,831     -
   Martin Samuel Bates SVP and CFO   •       –      –    2021-12-23 4 AS $42.00 $399,000 D/D (9,500) 24,378 -24%     
   Martin Samuel Bates SVP and CFO   •       –      –    2021-12-23 4 OE $2.78 $39,729 D/D 7,000 33,878     -
   Heath-Chiozzi Margo SVP of Regulatory Affairs   •       –      –    2021-12-08 4 AS $40.00 $24,000 D/D (600) 11,247 -13%     
   Heath-Chiozzi Margo SVP of Regulatory Affairs   •       –      –    2021-12-08 4 OE $2.78 $1,668 D/D 600 11,847     -
   Cavanaugh Sarah SVP of Corp Affairs & Admin.   •       –      –    2021-12-08 4 AS $40.00 $292,920 D/D (7,323) 408 -13%     
   Cavanaugh Sarah SVP of Corp Affairs & Admin.   •       –      –    2021-12-08 4 OE $9.02 $73,481 D/D 7,323 7,731     -
   Crowley Elizabeth Sr. VP &CPDO   •       –      –    2021-12-08 4 AS $40.00 $160,000 D/D (4,000) 4,726 -13%     
   Crowley Elizabeth Sr. VP &CPDO   •       –      –    2021-12-08 4 OE $9.02 $36,066 D/D 4,000 8,726     -
   Martin Samuel Bates SVP and CFO   •       –      –    2021-11-15 4 AS $42.27 $413,883 D/D (9,500) 26,878 -17%     
   Martin Samuel Bates SVP and CFO   •       –      –    2021-11-15 4 OE $2.78 $39,729 D/D 7,000 36,378     -
   Young Diane C. SVP, Chief Medical Officer   •       –      –    2021-11-12 4 S $42.94 $197,529 D/D (4,600) 2,115 19%     
   Young Diane C. SVP, Chief Medical Officer   •       –      –    2021-11-12 4 OE $10.38 $47,748 D/D 4,600 6,715     -
   Cavanaugh Sarah SVP of Corp Affairs & Admin.   •       –      –    2021-11-01 4 AS $41.62 $316,804 D/D (7,323) 408 -29%     
   Cavanaugh Sarah SVP of Corp Affairs & Admin.   •       –      –    2021-11-01 4 OE $2.78 $47,852 D/D 5,956 7,731     -
   Heath-Chiozzi Margo SVP of Regulatory Affairs   •       –      –    2021-11-01 4 AS $41.71 $25,026 D/D (600) 11,247 -29%     
   Heath-Chiozzi Margo SVP of Regulatory Affairs   •       –      –    2021-11-01 4 OE $2.78 $1,668 D/D 600 11,847     -
   Crowley Elizabeth Sr. VP &CPDO   •       –      –    2021-11-01 4 AS $41.62 $186,874 D/D (4,317) 4,726 -29%     
   Crowley Elizabeth Sr. VP &CPDO   •       –      –    2021-11-01 4 OE $2.78 $23,783 D/D 8,555 9,043     -
  254 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us